Robbie Williams Attributes Weight Loss To Ozempic-Like Drug In Upcoming Netflix Documentary: 'It's Like A Christmas Miracle'

British singer-songwriter Robbie Williams has attributed his significant weight loss to a drug similar to Ozempic, revealing that his weight gain has grave impacts on his mental health.

Robbie admitted in a new interview that gaining weight can be “shockingly catastrophic” to his mental health, reported Express.

“Babe, I’m on Ozempic. Well, something like Ozempic. It’s like a Christmas miracle,” he said, referring to the “miracle” weight loss drug that has taken Hollywood by storm.

See Also: Even As Women Remain A Rarity In Corporate Leadership, The Team At Nanotech Firm FendX Is Setting The Right Example

Since taking the Ozempic-like drug, Williams disclosed he had lost over a stone, adding, “And I need it, medically. I’ve been diagnosed with type 2 self-loathing.”

A forthcoming Netflix documentary on Robbie will unfold his journey including his rise to fame, his public breakdown, and his struggles with weight and mental health. The four-part series, set to air on Nov. 8, will feature never-before-seen footage of Robbie along with new interviews.

Robbie, who has been candid about his ongoing battle with mental illness, reached his lowest point when his fame was at its peak. He battled agoraphobia from 2006 to 2009 and went into rehab in 2007 after using several illegal and prescription drugs. The singer is now sober and lives with his wife Ayda Field and their four children.

Read Next: FDA Gives Nod To Eli Lilly’s First Treatment For Type Of Inflammatory Bowel Disease, To Compete With JNJ, Pfizer, AbbVie

Image Via Shutterstock


Engineered by Benzinga Neuro, Edited by Pooja Rajkumari


The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. Learn more.


Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!